LLY

778.49

+1.1%↑

JNJ

152.25

+0.62%↑

ABBV

185.54

+0.9%↑

NVO

70.68

+1.29%↑

UNH

305.52

+1.55%↑

LLY

778.49

+1.1%↑

JNJ

152.25

+0.62%↑

ABBV

185.54

+0.9%↑

NVO

70.68

+1.29%↑

UNH

305.52

+1.55%↑

LLY

778.49

+1.1%↑

JNJ

152.25

+0.62%↑

ABBV

185.54

+0.9%↑

NVO

70.68

+1.29%↑

UNH

305.52

+1.55%↑

LLY

778.49

+1.1%↑

JNJ

152.25

+0.62%↑

ABBV

185.54

+0.9%↑

NVO

70.68

+1.29%↑

UNH

305.52

+1.55%↑

LLY

778.49

+1.1%↑

JNJ

152.25

+0.62%↑

ABBV

185.54

+0.9%↑

NVO

70.68

+1.29%↑

UNH

305.52

+1.55%↑

Search

Masimo Corp

Gesloten

SectorGezondheidszorg

170 1.29

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

166.08

Max

170.5

Belangrijke statistieken

By Trading Economics

Inkomsten

397M

47M

Verkoop

-229M

372M

K/W

Sectorgemiddelde

118.556

50.857

EPS

1.36

Winstmarge

12.688

Werknemers

3,600

EBITDA

407M

86M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+12.78% upside

Dividenden

By Dow Jones

Volgende Winsten

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-690M

8.8B

Vorige openingsprijs

168.71

Vorige sluitingsprijs

170

Nieuwssentiment

By Acuity

50%

50%

168 / 380 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Masimo Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 mei 2025, 20:32 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Masimo to Sell Audio Business to Harman in $350 Million Deal -- Update

6 mei 2025, 20:12 UTC

Acquisities, Fusies, Overnames

Masimo: Divestiture Supports Focus on Core Professional Healthcare Business >MASI

6 mei 2025, 20:12 UTC

Acquisities, Fusies, Overnames

Masimo to Sell Sound United Consumer Audio Business to Samsung's HARMAN for $350 M in Cash >MASI

6 mei 2025, 20:00 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Masimo to Sell Audio Business to Harman After Investor Outrage -- WSJ

6 mei 2025, 20:00 UTC

Acquisities, Fusies, Overnames

Harman International Nears $350M Deal for Masimo's Consumer Audio Business, Sources Say -- WSJ

6 mei 2025, 20:00 UTC

Acquisities, Fusies, Overnames

Deal Could be Finalized as Soon as Later Tuesday, Sources Say -- WSJ

Peer Vergelijking

Prijswijziging

Masimo Corp Prognose

Koersdoel

By TipRanks

12.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 189.6 USD  12.78%

Hoogste 200 USD

Laagste 180 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Masimo Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Technische score

By Trading Central

142.8 / 163.949Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Very Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

168 / 380 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Masimo Corp

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.